SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Market Cap	3.59B
Revenue (ttm)	1.30B
Net Income (ttm)	381.65M
Shares Out	44.59M
EPS (ttm)	8.54
PE Ratio	9.43
Forward PE	n/a
Dividend	5.30 (6.58%)
Ex-Dividend Date	Jul 21, 2025

Volume	129,255
Average Volume	57,468
Open	81.30
Previous Close	80.50
Day's Range	79.00 - 81.30
52-Week Range	79.00 - 110.00
Beta	-0.11
RSI	27.87
Earnings Date	Aug 6, 2025

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, antihypertensive, α- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anest...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 227
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2024, SYN-TECH Chem. & Pharm.'s revenue was 1.26 billion, an increase of 12.83% compared to the previous year's 1.11 billion. Earnings were 393.28 million, an increase of 56.68%.